2014
DOI: 10.1016/j.bjhh.2014.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…In MDS, the most commonly found mutations affect ribonucleic acid (RNA) splicing (SF3B1, SRSF2, ZRSR2, U2AF1/2), deoxyribonucleic acid (DNA) methylation (TET2, DNMT3A, IDH1/2), chromatin modification (ASXL1, EZH2) (1,2,7) and the p53 gene. (8,9) Distinguishing cytopenia related to MDS or nonclonal disease is a complex challenge. Myelodysplastic syndromes diagnosis requires a combination of several methods.…”
Section: ❚ Resumomentioning
confidence: 99%
“…In MDS, the most commonly found mutations affect ribonucleic acid (RNA) splicing (SF3B1, SRSF2, ZRSR2, U2AF1/2), deoxyribonucleic acid (DNA) methylation (TET2, DNMT3A, IDH1/2), chromatin modification (ASXL1, EZH2) (1,2,7) and the p53 gene. (8,9) Distinguishing cytopenia related to MDS or nonclonal disease is a complex challenge. Myelodysplastic syndromes diagnosis requires a combination of several methods.…”
Section: ❚ Resumomentioning
confidence: 99%